Objective To analyze the influencing factors of recurrence after cure in 202 newly treated smear-positive pulmonary tuberculosis patients. Methods A total of 202 newly treated smear-positive pulmonary tuberculosis patients were selected from April 2017 to July 2019 in Puyang Fifth People's Hospital.After treatment,they were followed up for two years.The patients were divided into recurrent group (15 cases) and non-recurrent group (187 cases) according to whether they recurred.The general data such as gender,age,occupation,education level,and clinical data such as whether diabetes,low protein,and the amount of sputum smear bacteria at the first diagnosis were collected and compared between the two groups.Logistic regression model was used to analyze the risk factors of recurrence in patients with smear-positive pulmonary tuberculosis after treatment. Results The recurrence rate of 202 patients with smear-positive pulmonary tuberculosis was 7.43% (15/202) after 2 years of cure.There were significant differences between the two groups in age,diabetes,time of sputum bacteria turning negative,residual cavity after drug withdrawal,and bacterial count of sputum smear at the first diagnosis (P<0.05).Logistic regression analysis showed that the patients were≥60 years old (OR=6.799,95%CI:2.847-16.239),complicated with diabetes (OR=4.622,95%CI:1.159-18.436),the time of sputum bacteria turning negative was≥3 months (OR=7.336,95%CI:3.622-14.858),residual cavities after drug withdrawal (OR=4.182,95%CI:4.182-17.031),and the amount of sputum smear bacteria at the first diagnosis was 2+(OR=5.526,95%CI:1.657-18.426),3+(OR=7.039,95%CI:3.522-14.067),4+(OR=9.979,95%CI:5.071-19.639),were the influencing factors of relapse after cure in the patients with smear-positive pulmonary tuberculosis. Conclusion There is a certain level of recurrence rate in the first treatment smear-positive pulmonary tuberculosis patients within 2 years after cure.The older the patients are,the combination of diabetes,the time of sputum bacteria turning negative,the residual cavity after drug withdrawal,and the amount of bacteria in the first diagnosis sputum smear are the factors that affect the recurrence of the first treatment smear-positive pulmonary tuberculosis patients after cure.
Key words
Pulmonary tuberculosis /
Recurrence /
Influencing factors /
Logistic analysis
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] Da Silva EH,Lima E,Dos Santos TR,et al.Prevalence and incidence of tuberculosis in health workers:A systematic review of the literature[J].Am J Infect Control,2022,50(7):820-827.
[2] 姚叶萍,关玉娟.2017—2020年广州市增城区肺结核病流行特征分析[J].中国感染与化疗杂志,2022,22(3):260-264.
[3] Von Groote-Bidlingmaier F,Patientia R,Sanchez E,et al.Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis:a multicentre,randomised,double-blind,placebo-controlled,parallel group phase 3 trial[J].Lancet Respir Med,2019,7(3):249-259.
[4] 于海娟,赵梅,王佳月,等.肺结核患者结核杆菌耐药情况及耐多药结核病的危险因素[J].中国感染控制杂志,2020,19(1):58-62.
[5] Lan Z,Ahmad N,Baghaei P,et al.Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis[J].Lancet Respir Med,2020,8(4):383-394.
[6] 张素娟,韩彦周,李华,等.初治涂阳肺结核患者抗结核治疗不良反应发生现状及影响因素分析[J].河北医科大学学报,2021,42(5):536-540.
[7] 中华医学会.肺结核基层诊疗指南(2018年)[J].中华全科医师杂志,2019,18(8):709-717.
[8] 赵雁林,陈明亭.《中国结核病防治工作技术指南》(2021)[M].人民卫生出版社,2021:228-229.
[9] 李鹰,王祖康,魏尤良,等.初治涂阳肺结核患者治愈后的随访观察及复发情况的影响因素分析[J].中国全科医学,2021,24(14):1785-1789.
[10] 孙玉柱.237例初治涂阳肺结核患者抗结核化疗愈后复发的危险因素分析[J].首都食品与医药,2021,28(17):113-114.
[11] 高丽,庞学文,张国钦,等.天津市初治活动性肺结核患者成功治疗后2年内复发的危险因素分析[J].中国防痨杂志,2022,44(7):698-703.
[12] Chen Z,Liu Q,Song R,et al.The association of glycemic level and prevalence of tuberculosis: a meta-analysis[J].BMC Endocr Disord,2021,21(1):123.
[13] 徐静,罗萍,贺晓新.肺结核合并糖尿病与单纯肺结核患者流行特征对比分析[J].中国防痨杂志,2022,44(5):494-499.
[14] Song C,Xie W,Gong L,et al.The relationship between HbA1c control levels and antituberculosis treatment effects: a meta-analysis[J].J Chin Med Assoc,2019,82(12):915-921.
[15] 雷蓉蓉,汪清雅,张婷.重庆市肺结核患者复发情况及影响因素分析[J].中国热带医学,2020,20(11):1092-1095.
[16] 庄建文,韩湉湉,黎小兰,等.肺结核患者反复住院治疗的原因及危险因素分析[J].实用预防医学,2022,29(5):620-622.